Sterne Kessler Directors Deborah Sterling and Jeremiah Frueauf hosted a roundtable on “IP and Exclusivity Strategies for Navigating CGT Innovations From Conception to Commercialization” during the Advanced Therapies Europe 2025 conference in Barcelona.

Advanced Therapies Europe is an exclusive meeting for the most influential minds in cell and gene therapy. Hosted in one of Europe’s fastest-growing biotech hubs, the conference connected therapeutic developers, pharma leaders, CDMOs, and investors in one focused environment.